Clinical Trial Update: Phase I Study of GSK233705 in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

Phase I study of GSK233705 in healthy Japanese male volunteers has completed; the trial investigated safety and pharmacokinetics in relation to chronic obstruct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK233705

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED